On April 11, 2023 Kiyatec, the leader in clinically correlated, published functional precision oncology technology, reported that two abstracts were accepted for poster presentations at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting to be held in Orlando, Florida from April 14 – 19, 2023 (Press release, Kiyatec, APR 11, 2023, View Source [SID1234629974]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Kiyatec’s clinical and pre-clinical technology platforms, 3D Predict and KIYA-PREDICT, respectively, are leading the functional precision oncology space with published evidence of predictive response correlated to clinical outcomes. The two abstracts accepted for presentation at the conference highlight the companies work in ex vivo immune-oncology applications for pre-clinical drug development, including multiple mechanisms of action, utilization of ex vivo PDX, and development of advanced organoid technology. The ex vivo PDX work features an ongoing collaboration with investigators from XenoSTART.
"The work being presented highlights the application of Kiyatec’s technologies for the development and testing of multiple types of immunotherapies," said Tessa DesRochers, Kiyatec’s Chief Scientific Officer. "Our technology platforms allow for testing of I/O agents on primary patient tissue and ex vivo PDX tissue, providing expanded, more relevant avenues for drug development in immuno-oncology."
Session titles and information for the abstracts are listed below and are also available on the AACR (Free AACR Whitepaper) online itinerary planner. Kiyatec will exhibit it’s preclinical service offerings at AACR (Free AACR Whitepaper) at Booth #419.
Kiyatec presentation schedule:
Preclinical testing of therapeutic biologics using patient-derived 3D Spheroids
Clinical Research Excluding Trials
Monday, April 17th 9:00am – 12:30pm
Perfused patient-derived tumor organoid models with autologous immune cells for preclinical drug development
Tumor Organoids for Therapeutic Testing
Sunday, April 16th 1:30pm – 5:00pm